Skip to main content

From mine to medicine, we're pioneers in iron-based therapies. We've been around for seven decades, honing our manufacturing excellence and securing a resilient supply chain to help people live better lives.

Everything we do is guided by experts. In the fields of iron deficiency and iron deficiency anemia, nothing can be left to chance. That's why we produce our own iron chloride, design some manufacturing equipment in-house, and combine state-of-the-art technology with human expertise for better quality control.

We're committed to improving patient's health. And we believe that starts with quality materials, strengthens with quality manufacturing, and endures with quality outcomes.

Stay up-to-date with all our latest insights and announcements in the field of iron medicine by hitting 'subscribe' below.

Mine to medicine overview

“CSL Vifor St Gallen is historically known as our 'Home of Iron.' It's where the first IV solution was produced in 1949. Take a tour of our manufacturing site and uncover the meticulous processes that go into honing our iron therapies.”

Manuel Senn
Manuel Senn
Site Head St. Gallen
Manufacturing Operations
Manufacturing

Guided by experts

We carefully control every aspect of our manufacturing, including designing some of our equipment in-house with our team of engineers and chemical experts. In addition, human supervision remains essential in managing critical steps in the manufacturing process. Learn more about how we maintain consistency and excellence.

Learn more

Built on a rich heritage

Caspar Hausmann
A portrait of Caspar Hausmann
Caspar Hausmann’s St. Gallen pharmacy pioneers iron products

This moment marked the beginning of a legacy. Driven by a deep commitment to addressing iron deficiency, Hausmann’s early innovations laid the groundwork for what would become over a century of progress in iron therapy. His vision and scientific curiosity continue to inspire our work today.

Vifor Ltd. established
Vifor Ltd. established, marketing hospital supply products

The foundation of Vifor Ltd. in Switzerland marked a pivotal step in our evolution. Initially focused on hospital supplies, the company quickly built a reputation for reliability and quality – principles that remain at the heart of everything we do. This era set the stage for future breakthroughs in pharmaceutical care.

Laboratories Hausmann Ltd founded
Laboratories Hausmann Ltd founded

With the formation of Laboratories Hausmann Ltd., our dedication to iron therapy deepened. This milestone represented a commitment to scientific rigour, enabling focused research and development that would elevate standards in patient treatment spanning generations.

Galenica acquires Vifor Ltd
Galenica acquires Vifor Ltd.

The acquisition of Vifor Ltd. by Galenica marked a new chapter of growth. It brought fresh energy, broader capabilities, and a renewed focus on addressing unmet medical needs – laying the foundation for a dynamic, integrated pharmaceutical group.

Galenica acquires Laboratories Hausmann
Galenica acquires Laboratories Hausmann

Bringing Laboratories Hausmann into the Galenica family united two pioneers under one vision. Together, they formed a stronger force in iron therapy, blending deep scientific expertise with a growing ambition to serve patients more holistically.

Vifor (International) AG Founded by Galenica
Vifor (International) AG Founded by Galenica

The creation of Vifor (International) AG reflected a growing global ambition. As we reached beyond borders, we remained grounded in Swiss quality and innovation, sharing our expertise worldwide while staying true to our roots in precision and care.

Vifor Fresenius Medical Care Renal Pharma
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) established

The launch of VFMCRP represented a deepened focus on patients with chronic kidney disease. This strategic partnership combined strengths to develop and deliver solutions for some of the most pressing challenges in renal care – always with the patient at the centre.

Vifor Pharma becomes independent, stock-listed company
Vifor Pharma becomes independent, stock-listed company

Becoming an independent, publicly listed company was a defining moment. It gave Vifor Pharma the autonomy to forge its own path, accelerate innovation, and grow with purpose, all while honouring the legacy that brought us here.

Vifor Pharma acquires Sanifit Therapeutics and Inositec
Vifor Pharma acquires Sanifit Therapeutics and Inositec

Our acquisition of Sanifit Therapeutics and Inositec signalled a bold step into new areas of innovation. These additions strengthened our position in cardio-renal care and rare diseases, expanding the scope of our mission to improve lives through science.

CSL Limited acquires Vifor Pharma
CSL Limited acquires Vifor Pharma

“Together we are stronger, with complementary capabilities that enhance our global therapeutic positions, capacity for innovation, scale and growth potential,” CSL CEO and Managing Director Paul Perreault said of the acquisition finalized on August 9.

Nanoparticles

Simplifying the complexity
of nanomedicines

We're on a mission to help you understand the complexities of nanomedicine. By breaking down its incredible role in iron based therapies and simplifying the science, we hope to show you the true power of particles.

Learn more

Find out more

L2hvbWVwYWdl